US Stock MarketDetailed Quotes

CC The Chemours

Watchlist

26.190
-0.290-1.10%

Trading Apr 19 11:15 ET

3.90BMarket Cap-16368P/E (TTM)

The Chemours Stock Forum

Movers and Shakers

Mar 28 20:32

ColumnsToday's Morning Movers and Top Ratings: EL, BAC, ALL, RH and More

Morning Movers
Gapping up
$Estee Lauder(EL.US)$ Shares soared over 3% following an upgrade to buy from neutral by Bank of America, which referenced the company's profitability recovery efforts, new products, and growing market share in the prestige beauty sector.
$Allstate(ALL.US)$ The insurance stock climbed 0.9% after HSBC raised its rating to buy from hold, with analyst Vikram Gandhi commending the company's "decisive management...

Moomoo AI

Mar 28 07:02

The revelation of material weaknesses in Chemours' financial reporting and the manipulation of vendor payments and receivables by top executives could negatively impact investor confidence and the company's stock price.

Chemours Finds Material Weaknesses After Internal Review, Stock Slumps ~11% After Hours

Moomoo AI

Mar 28 05:49

Chemours' ongoing investigation and executive suspension could hurt investor confidence and stock price, despite a narrower Q4 loss and higher revenue.

Chemours Responds to Regulators, Prosecutors About Internal Audit

Moomoo AI

Mar 8 02:20

Chemours' top executives' manipulation of cash flows to meet annual stock and bonus targets raises concerns about the company's accounting practices, potentially impacting investor confidence and future stock price.

Chemours Executives Improperly Shifted Deals to Boost Their Pay, Probe Finds -- WSJ

Moomoo AI

Mar 1 19:20

The stock's decline is understandable due to low revenue growth and lack of profits. The key question is the company's path to profitability. Consider adding it to your watchlist until it makes its maiden profit. Significant insider purchases in the last year could be a positive sign.

Chemours (NYSE:CC Shareholders Incur Further Losses as Stock Declines 34% This Week, Taking Five-year Losses to 36%

Moomoo AI

Mar 1 04:49

Chemours' accounting issues are more severe than initially thought, causing major leadership changes and a delay in financial reporting. This led to a record selloff of the company's stock, potentially impacting future financial performance.

Chemours's Stock Plunges on News That Accounting Issues Are Much Worse Than First Thought

Moomoo AI

Mar 1 02:27

The internal investigation and delay in financial filings have spooked investors, causing a sharp drop in the company's stock. The decision to stay in the 'forever-chemicals' business, despite competitors exiting due to liability claims, could be a concern for investors. The review of the company's ethics hotline suggests broader and deeper issues than just financial reporting.

Chemical Giant Chemours Stock Tumbles 32% Amid Potential Accounting Scandal

Moomoo AI

Feb 29 23:33

Accounting issues leading to delayed earnings report and key executives' leave have shaken investor confidence in Chemours, causing a stock price plunge. The company's future hinges on the internal review outcome and interim leadership effectiveness.

Chemours Stock Craters. CEO, CFO Put on Leave and Earnings Delayed as Company Reviews Accounting Issues. -- Barrons.com

102667445

Feb 15 22:40

found this company thru krytox lol

$The Chemours(CC.US)$

Moomoo AI

Nov 25, 2023 03:58

The less-than-stellar performance of Chemours' stock due to shrinking revenues and continued unprofitability contrasts their promising policy of reinvesting dividends. Long-term shareholders may see potential in the recent sell-off, backed by a 3% annual gain over five years.

Chemours (NYSE:CC Shareholders Incur Further Losses as Stock Declines 3.9% This Week, Taking One-year Losses to 17%

No comment yet

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall